Loading insider details...
Beta
Latest Form 4 (Sep 3, 2026): Sale of 1,215 REGN shares, $1.03M.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 3, 2026 | REGENERON PHARMACEUTICALS, INC. (REGN) | Sale | 1,215 | $1.03M |
| Dec 11, 2025 | REGENERON PHARMACEUTICALS, INC. (REGN) | Tax Withholding | 1,021 | $716.2K |
| Dec 9, 2025 | REGENERON PHARMACEUTICALS, INC. (REGN) | Grant/Award | 2,476 | n/a |
| Dec 18, 2024 | REGENERON PHARMACEUTICALS, INC. (REGN) | Tax Withholding | 759 | $554.7K |
| Dec 10, 2024 | REGENERON PHARMACEUTICALS, INC. (REGN) | Grant/Award | 2,332 | n/a |
| Nov 5, 2024 | REGENERON PHARMACEUTICALS, INC. (REGN) | Exercise/Conversion | 1,000 | $381.4K |
| Oct 3, 2024 | REGENERON PHARMACEUTICALS, INC. (REGN) | Exercise/Conversion | 1,000 | $381.4K |
| Sep 5, 2024 | REGENERON PHARMACEUTICALS, INC. (REGN) | Exercise/Conversion | 1,000 | $381.4K |
| Aug 5, 2024 | REGENERON PHARMACEUTICALS, INC. (REGN) | Exercise/Conversion | 1,137 | $423.5K |
| Jul 2, 2024 | REGENERON PHARMACEUTICALS, INC. (REGN) | Exercise/Conversion | 1,137 | $423.5K |